4
Changes in Ownership
IRONWOOD PHARMACEUTICALS INC Filed Acc 0000950170-24-015548
SVP, Chief Business Officer sold 9,846 shares at $15.24 ($150,053)
- SVP, Chief Business Officer acquired 65,312 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Davis Andrew SVP, Chief Business Officer | 2024-02-12 | Sale | −9,846 | $15.24 | $150,053 | 208,324 | D |
| Davis Andrew SVP, Chief Business Officer | 2024-02-12 | Grant or award | +65,312 | 273,636 | D | ||
| Derivatives | |||||||
| Davis Andrew SVP, Chief Business Officer | 2024-02-12 | Grant or award · Performance-based Restricted Stock Unit | +32,656 | 32,656 | D | ||
| Open-market sales · 9,846 sh · avg $15.24 · $150,053 | |||||||
Loading xslF345X05/ownership.xml…